Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17204738rdf:typepubmed:Citationlld:pubmed
pubmed-article:17204738lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:17204738lifeskim:mentionsumls-concept:C0003364lld:lifeskim
pubmed-article:17204738lifeskim:mentionsumls-concept:C0546816lld:lifeskim
pubmed-article:17204738lifeskim:mentionsumls-concept:C0457454lld:lifeskim
pubmed-article:17204738lifeskim:mentionsumls-concept:C1510802lld:lifeskim
pubmed-article:17204738lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:17204738lifeskim:mentionsumls-concept:C0278329lld:lifeskim
pubmed-article:17204738lifeskim:mentionsumls-concept:C1444662lld:lifeskim
pubmed-article:17204738pubmed:issue1lld:pubmed
pubmed-article:17204738pubmed:dateCreated2007-1-5lld:pubmed
pubmed-article:17204738pubmed:abstractTextTo assess 1-year persistence and adherence with monotherapy using the most commonly dispensed individual agent in 4 antihypertensive drug classes: hydrochlorothiazide (HCTZ), amlodipine, lisinopril, or valsartan.lld:pubmed
pubmed-article:17204738pubmed:languageenglld:pubmed
pubmed-article:17204738pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17204738pubmed:citationSubsetIMlld:pubmed
pubmed-article:17204738pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17204738pubmed:statusMEDLINElld:pubmed
pubmed-article:17204738pubmed:issn1557-2625lld:pubmed
pubmed-article:17204738pubmed:authorpubmed-author:ElliottWillia...lld:pubmed
pubmed-article:17204738pubmed:authorpubmed-author:GauseDouglasDlld:pubmed
pubmed-article:17204738pubmed:authorpubmed-author:SkrepnekGrant...lld:pubmed
pubmed-article:17204738pubmed:authorpubmed-author:PlauschinatCr...lld:pubmed
pubmed-article:17204738pubmed:issnTypePrintlld:pubmed
pubmed-article:17204738pubmed:volume20lld:pubmed
pubmed-article:17204738pubmed:ownerNLMlld:pubmed
pubmed-article:17204738pubmed:authorsCompleteYlld:pubmed
pubmed-article:17204738pubmed:pagination72-80lld:pubmed
pubmed-article:17204738pubmed:meshHeadingpubmed-meshheading:17204738...lld:pubmed
pubmed-article:17204738pubmed:meshHeadingpubmed-meshheading:17204738...lld:pubmed
pubmed-article:17204738pubmed:meshHeadingpubmed-meshheading:17204738...lld:pubmed
pubmed-article:17204738pubmed:meshHeadingpubmed-meshheading:17204738...lld:pubmed
pubmed-article:17204738pubmed:meshHeadingpubmed-meshheading:17204738...lld:pubmed
pubmed-article:17204738pubmed:meshHeadingpubmed-meshheading:17204738...lld:pubmed
pubmed-article:17204738pubmed:meshHeadingpubmed-meshheading:17204738...lld:pubmed
pubmed-article:17204738pubmed:meshHeadingpubmed-meshheading:17204738...lld:pubmed
pubmed-article:17204738pubmed:meshHeadingpubmed-meshheading:17204738...lld:pubmed
pubmed-article:17204738pubmed:meshHeadingpubmed-meshheading:17204738...lld:pubmed
pubmed-article:17204738pubmed:meshHeadingpubmed-meshheading:17204738...lld:pubmed
pubmed-article:17204738pubmed:meshHeadingpubmed-meshheading:17204738...lld:pubmed
pubmed-article:17204738pubmed:meshHeadingpubmed-meshheading:17204738...lld:pubmed
pubmed-article:17204738pubmed:meshHeadingpubmed-meshheading:17204738...lld:pubmed
pubmed-article:17204738pubmed:articleTitlePersistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapies.lld:pubmed
pubmed-article:17204738pubmed:affiliationDepartment of Preventive Medicine, Rush Medical College at Rush University Medical Center, Chicago, IL, USA. welliott@rush.edulld:pubmed
pubmed-article:17204738pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17204738pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17204738lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17204738lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17204738lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17204738lld:pubmed